Table 1 Demographic and clinical characteristics of the study population
Characteristics | Mono-HIV infected group (n = 10) | HIV/Tb co-infected group (n = 13) | P-value |
|---|---|---|---|
Age (years), mean ± SD | 39.50 ± 11.28 | 38.00 ± 11.09 | 0.40 |
Male | 80.00% | 69.23% | 0.66 |
Baseline CD4 T cell count (cells/μl), median (IQR) | 152.00 (44.00–252.00) | 101.00 (55.00–173.00) | 0.41 |
Baseline CD4/CD8 T cell ratio | 0.20 (0.07–0.48) | 0.26 (0.08–0.36) | 0.99 |
EFV based | 70.00% | 92.31% | 0.24 |
Duration of ART (Months) | 12.15 (11.53–14.91) | 18.00 (17.00–23.00) | <0.0001 |
On-ART CD4 T cell count (cells/μl), median (IQR) | 453.00 (304.75–475.75) | 283.00 (215.00–388.50) | 0.04 |
On-ART CD4/CD8 T cell ratio | 0.54 (0.36–0.88) | 0.30 (0.16–0.45) | 0.03 |
Baseline viral load (Log10 copies/ml), median (IQR) | 4.57 (4.36–5.35) | 5.77 (5.23–6.00) | 0.003 |